Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Healthcare Biotechnology
Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care... see more

Recent & Breaking News (TSXV:COV)

Covalon Announces Closing of Non-Brokered Private Placement and Exercise of Warrants

Business Wire June 1, 2017

Covalon Releases Second Quarter Financial Results

Business Wire May 29, 2017

Covalon Announces Conference Call to Discuss Q2 Financial Results

Business Wire May 26, 2017

Covalon Engages Advisors to Pursue Strategic Acquisitions

Business Wire May 16, 2017

Covalon Announces $2.6 Million Private Placement and Warrant Exercise

Business Wire May 12, 2017

Covalon to Present IV Clear at the 42nd Annual Oncology Nursing Society Congress

Business Wire May 4, 2017

Covalon to Exhibit at the 2017 European Wound Management Association’s Annual Conference

Business Wire May 3, 2017

Covalon Launches Centaur™ Low Particulate, Lubricious Coating for Medical Devices

Business Wire April 27, 2017

Clinical Effectiveness of Covalon’s ColActive Plus to be Presented at SAWC Spring Meeting

Business Wire April 5, 2017

Covalon Announces Issuance of Stock Options

Business Wire February 9, 2017

Covalon Posts Record First Quarter Financial Results

Business Wire January 30, 2017

Covalon Announces Conference Call to Discuss Year End and First Quarter Financial Results

Business Wire January 27, 2017

Covalon CEO Provides Update on Anticipated Fiscal 2017 Financial Growth

Business Wire January 3, 2017

Covalon to Showcase ColActive® Brand of Advanced Bio-Matrix Dressings at the Symposium on Advanced Wound Care

Business Wire October 7, 2016

Covalon to Exhibit at the World Union of Wound Healing Societies in Florence, Italy

Business Wire September 26, 2016

Covalon to Showcase IV Clear to Pediatric Specialists at the Association for Vascular Access Annual Meeting

Business Wire September 16, 2016

Covalon Announces Issuance of Stock Options

Business Wire September 15, 2016

Covalon Establishes Key Distribution Channel in Mexico

Business Wire September 13, 2016

The Goldfarb Corporation Acquires Additional Shares of Covalon Technologies Ltd.

Business Wire August 29, 2016

Covalon Announces Exercise of Warrants

Business Wire August 29, 2016